5WYH
Crystal structure of RidL(1-200) complexed with VPS29
Summary for 5WYH
Entry DOI | 10.2210/pdb5wyh/pdb |
Descriptor | Vacuolar protein sorting-associated protein 29, Interaptin, GLYCEROL, ... (4 entities in total) |
Functional Keywords | complex vps29 ridl, metal binding protein-protein binding complex, metal binding protein/protein binding |
Biological source | Homo sapiens (Human) More |
Cellular location | Cytoplasm: Q9UBQ0 |
Total number of polymer chains | 4 |
Total formula weight | 87513.37 |
Authors | |
Primary citation | Yao, J.,Yang, F.,Sun, X.,Wang, S.,Gan, N.,Liu, Q.,Liu, D.,Zhang, X.,Niu, D.,Wei, Y.,Ma, C.,Luo, Z.Q.,Sun, Q.,Jia, D. Mechanism of inhibition of retromer transport by the bacterial effector RidL. Proc. Natl. Acad. Sci. U.S.A., 115:E1446-E1454, 2018 Cited by PubMed Abstract: Retrograde vesicle trafficking pathways are responsible for returning membrane-associated components from endosomes to the Golgi apparatus and the endoplasmic reticulum (ER), and they are critical for maintaining organelle identity, lipid homeostasis, and many other cellular functions. The retrograde transport pathway has emerged as an important target for intravacuolar bacterial pathogens. The opportunistic pathogen exploits both the secretory and recycling branches of the vesicle transport pathway for intracellular bacterial proliferation. Its Dot/Icm effector RidL inhibits the activity of the retromer by directly engaging retromer components. However, the mechanism underlying such inhibition remains unknown. Here we present the crystal structure of RidL in complex with VPS29, a subunit of the retromer. Our results demonstrate that RidL binds to a highly conserved hydrophobic pocket of VPS29. This interaction is critical for endosomal recruitment of RidL and for its inhibitory effects. RidL inhibits retromer activity by direct competition, in which it occupies the VPS29-binding site of the essential retromer regulator TBC1d5. The mechanism of retromer inhibition by RidL reveals a hotspot on VPS29 critical for recognition by its regulators that is also exploited by pathogens, and provides a structural basis for the development of small molecule inhibitors against the retromer. PubMed: 29386389DOI: 10.1073/pnas.1717383115 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.46 Å) |
Structure validation
Download full validation report